This section presents information about the death rate statistics
for the various types of Sexually Transmitted Diseases.
Disease | Death Rate Estimate | US deaths estimate | Statistic Used for Calculation |
| Syphilis |
unavailable |
|
No information
|
| HIV |
approx 1 in 302 or 0.33% or 900,000 people in USA |
900,000 Americans (NIAID, quarter are unaware) |
900,000 Americans (NIAID, quarter are unaware)
|
| AIDS |
N/A |
N/A |
No information
|
| Genital herpes |
N/A |
N/A |
67 million people (NIAID)
|
| Human Papillomavirus |
N/A |
N/A |
20 million Americans currently infected (NIAID; CDC 2001)
|
| Chlamydia |
N/A |
N/A |
No information
|
| Gonorrhea |
N/A |
N/A |
No information
|
| HTLV |
N/A |
N/A |
uncommon
|
| chancroid |
N/A |
N/A |
No information
|
| cytomegalovirus |
N/A |
N/A |
50% approximately; almost half of young adults (NIAID)
|
| molluscum contagiosum |
N/A |
N/A |
Common.
|
| pubic lice |
N/A |
N/A |
No information
|
| scabies |
N/A |
N/A |
common
|
| Trichomoniasis |
N/A |
N/A |
No information
|
| bacterial vaginosis |
N/A |
N/A |
16% of pregnant women (DSTD)
|
| Granuloma inguinale |
N/A |
N/A |
No information
|
| Non-Specific Urethritis |
N/A |
N/A |
No information
|
| Hepatitis B |
N/A |
N/A |
estimated 1.5 million HBV carriers in the U.S. (NWHIC); 417,000 people currently infected (CDC 2001)
|
| Syphilis -- Teratogenic Agent |
N/A |
N/A |
No information
|
| Human carcinogen -- Chronic Hepatitis C viral infection |
N/A |
N/A |
No information
|
| Human carcinogen -- Human Immunodeficiency Virus Type 1 infection |
N/A |
N/A |
No information
|
| Human carcinogen -- Infection with Human papillomavirus type 16 |
N/A |
N/A |
No information
|
| Human carcinogen -- Infection with Human papillomavirus type 18 |
N/A |
N/A |
No information
|
| Human carcinogen -- Infection with Human papillomavirus type 31 |
N/A |
N/A |
No information
|
| Human carcinogen -- Infection with Human papillomavirus type 35 |
N/A |
N/A |
No information
|
| Human carcinogen -- Infection with Human papillomavirus type 39 |
N/A |
N/A |
No information
|
| Human carcinogen -- Infection with Human papillomavirus type 45 |
N/A |
N/A |
No information
|
| Human carcinogen -- Infection with Human papillomavirus type 51 |
N/A |
N/A |
No information
|
| Human carcinogen -- Infection with Human papillomavirus type 52 |
N/A |
N/A |
No information
|
| Human carcinogen -- Infection with Human papillomavirus type 56 |
N/A |
N/A |
No information
|
| Human carcinogen -- Infection with Human papillomavirus type 58 |
N/A |
N/A |
No information
|
| Human carcinogen -- Infection with Human papillomavirus type 59 |
N/A |
N/A |
No information
|
| Human carcinogen -- Infection with Human papillomavirus type 66 |
N/A |
N/A |
No information
|
| Hepatitis A |
N/A |
N/A |
No information
|
| Hepatitis C |
approx 1 in 136 or 0.74% or 2 million people in USA |
estimated 2 to 5 million HCV chronic carriers |
estimated 2 to 5 million HCV chronic carriers
|
| Viral Hepatitis |
unavailable |
|
No information
|
| Chronic Hepatitis B |
N/A |
N/A |
750,000 people in the United States (NIAID)
|
| Chronic Hepatitis C |
approx 1 in 68 or 1.47% or 4 million people in USA |
Almost 4 million Americans have antibodies indicating infection or prior exposure (NIDDK). |
Almost 4 million Americans have antibodies indicating infection or prior exposure (NIDDK).
|
| Syphilitic aseptic meningitis |
N/A |
N/A |
No information
|
| Possible human carcinogenic exposure -- Human immunodeficiency virus type 2 |
N/A |
N/A |
No information
|
| Possible human carcinogenic exposure -- Human papillomavirus types 6 and 11 |
N/A |
N/A |
No information
|
| Possible human carcinogenic exposure -- Human papillomavirus genus beta |
N/A |
N/A |
No information
|
| HIV-1A |
N/A |
N/A |
HIV-1Accounts for about 26.7% of cases of HIV worldwide
|
| HIV-1B |
N/A |
N/A |
HIV-1B accounts for about 12.3% of cases of HIV worldwide
|
| HIV-2A |
N/A |
N/A |
No information
|
| HIV-1C |
N/A |
N/A |
HIV-1C accounts for about 47.2% of cases of HIV worldwide
|
| HIV-2B |
N/A |
N/A |
No information
|
| HIV-1D |
N/A |
N/A |
HIV-1D accounts for about 5.3% of cases of HIV worldwide
|
| HIV-1E |
N/A |
N/A |
No information
|
| HIV-1F |
N/A |
N/A |
No information
|
| HIV-1G |
N/A |
N/A |
No information
|
| HIV-1H |
N/A |
N/A |
No information
|
| HIV-1J |
N/A |
N/A |
No information
|
| HIV-1K |
N/A |
N/A |
No information
|
| HIV-1M |
N/A |
N/A |
HIV-1M accounts for about 90% of cases of HIV worldwide
|
| HIV-1N |
N/A |
N/A |
No information
|
| HIV-1O |
N/A |
N/A |
No information
|
| HIV-1, CRF11_cpx |
N/A |
N/A |
No information
|
| HIV-1, CRF13_cpx |
N/A |
N/A |
No information
|
| HIV-1, CRF04_ cpx |
N/A |
N/A |
No information
|
| HIV-1, CRF06_cpx |
N/A |
N/A |
No information
|
| HIV-1, CRF25_cpx |
N/A |
N/A |
No information
|
| HIV-1, CRF21_A2D |
N/A |
N/A |
No information
|
| HIV-1, CRF32_06A1 |
N/A |
N/A |
No information
|
| HIV-1, CRF16_ A2D |
N/A |
N/A |
No information
|
| HIV-1, CRF22_01A1 |
N/A |
N/A |
No information
|
| HIV-1, CRF26_AU |
N/A |
N/A |
No information
|
| HIV-2 |
N/A |
N/A |
No information
|
| HIV-1, CRF36_cpx |
N/A |
N/A |
No information
|
| HIV-1, CRF27_cpx |
N/A |
N/A |
No information
|
| HIV-1, CRF18_cpx |
N/A |
N/A |
No information
|
| HIV-1, CRF37_cpx |
N/A |
N/A |
No information
|
| HIV-1, CRF19_cpx |
N/A |
N/A |
No information
|
| Pediatric AIDS |
N/A |
N/A |
No information
|
| HIV-1A1 |
N/A |
N/A |
No information
|
| HIV-1A2 |
N/A |
N/A |
No information
|
| HIV-1A3 |
N/A |
N/A |
HIV-1Accounts for about 26.7% of cases of HIV worldwide
|
| HIV-1F1 |
N/A |
N/A |
No information
|
| HIV-1F2 |
N/A |
N/A |
No information
|
| HIV-1, CRF01_AE |
N/A |
N/A |
HIV-1, CRF01_AE accounts for about 3.2% of cases of HIV worldwide
|
| HIV-1, CRF33_01B |
N/A |
N/A |
No information
|
| HIV-1, CRF31_BC |
N/A |
N/A |
No information
|
| HIV-1, CRF15_01B |
N/A |
N/A |
No information
|
| HIV-1, CRF34_01B |
N/A |
N/A |
No information
|
| HIV-1, CRF02_AG |
N/A |
N/A |
No information
|
| HIV-1, CRF30_0206 |
N/A |
N/A |
No information
|
| HIV-1, CRF20_BG |
N/A |
N/A |
No information
|
| HIV-1, CRF12_BF |
N/A |
N/A |
No information
|
| HIV-1, CRF41_CD |
N/A |
N/A |
No information
|
| HIV-1, CRF40_BF |
N/A |
N/A |
No information
|
| HIV-1, CRF07_BC |
N/A |
N/A |
No information
|
| HIV-1, CRF35_AD |
N/A |
N/A |
No information
|
| HIV-1, CRF08_BC |
N/A |
N/A |
No information
|
| HIV-1, CRF42_BF |
N/A |
N/A |
No information
|
| HIV-1, CRF23_BG |
N/A |
N/A |
No information
|
| HIV-1, CRF14_BG |
N/A |
N/A |
No information
|
| HIV-1, CRF24_BG |
N/A |
N/A |
No information
|
| HIV-1, CRF05_ D/F |
N/A |
N/A |
No information
|
| HIV-1, CRF43_02G |
N/A |
N/A |
No information
|
| HIV-1, CRF17_BF |
N/A |
N/A |
No information
|
| HIV-1, CRF28_BF |
N/A |
N/A |
No information
|
| HIV-1, CRF38_BF |
N/A |
N/A |
No information
|
| HIV-1, CRF29_BF |
N/A |
N/A |
No information
|
| HIV-1, CRF39_BF |
N/A |
N/A |
No information
|
| Chlamydial Infection |
N/A |
N/A |
No information
|
| Tumours related to AIDS |
N/A |
N/A |
No information
|
| Pulmonary infections related to AIDS |
N/A |
N/A |
No information
|
| Opportunistic infections related to HIV infection |
N/A |
N/A |
No information
|
| Gastrointestinal infections related to AIDS |
N/A |
N/A |
No information
|
| HIV related skin conditions |
N/A |
N/A |
No information
|
| Neurological disorders related to AIDS |
N/A |
N/A |
No information
|
| HIV like Severe sore throat |
N/A |
N/A |
No information
|
| AIDS-Associated Nephropathy |
N/A |
N/A |
No information
|
| AIDS-Related Complex |
N/A |
N/A |
No information
|
| AIDS-Related Opportunistic Infections |
N/A |
N/A |
No information
|
| AIDS wasting syndrome |
N/A |
N/A |
No information
|
| AIDS Dementia Complex |
N/A |
N/A |
No information
|
| Vaginosis (bacterial vaginosis) |
N/A |
N/A |
No information
|
| Neurosyphilis -- general paresis |
N/A |
N/A |
No information
|
| Genital warts |
N/A |
N/A |
No information
|
| HIV/AIDS |
approx 1 in 302 or 0.33% or 900,000 people in USA |
900,000 Americans (NIAID, quarter are unaware) |
900,000 Americans (NIAID, quarter are unaware)
|
| Lymphoma, AIDS-related |
N/A |
N/A |
No information
|
| Lipodystrophy-HIV related |
N/A |
N/A |
No information
|
| Tinea cruris |
N/A |
N/A |
No information
|
| Ureaplasma urealyticum |
N/A |
N/A |
No information
|
| Lymphogranuloma venereum |
N/A |
N/A |
No information
|
| Primary syphilis |
N/A |
N/A |
No information
|
| Secondary syphilis |
N/A |
N/A |
No information
|
| Tertiary syphilis |
N/A |
N/A |
No information
|
| Congenital syphilis |
N/A |
N/A |
No information
|
| HIV-associated eosinophilic folliculitis |
N/A |
N/A |
No information
|
| Treponema infection |
N/A |
N/A |
No information
|
| The clap |
N/A |
N/A |
No information
|
| Syphilis, latent |
N/A |
N/A |
No information
|
| Neurosyphilis |
N/A |
N/A |
No information
|
| Neurosyphilis -- asymptomatic |
N/A |
N/A |
No information
|
| Neurosyphilis -- tabes dorsalis |
N/A |
N/A |
No information
|
| Neurosyphilis -- meningovascular |
N/A |
N/A |
No information
|
| AIDS dysmorphic syndrome |
N/A |
N/A |
No information
|
| Condyloma |
N/A |
N/A |
No information
|
| Durand-Nicolas-Favre syndrome |
N/A |
N/A |
No information
|
The following medical news items are relevant to deaths and Sexually Transmitted Diseases:
